Characteristics
|
The training set
| |
The test set
| |
---|
|
MPE
|
BPE
|
P
|
MPE
|
BPE
|
P
|
---|
Age
| | | | | | |
< 60
|
112
|
39
|
0.069
|
84
|
24
|
0.149
|
≥ 60
|
162
|
35
| |
138
|
25
| |
Gender
| | | | | | |
Male
|
144
|
46
|
0.141
|
130
|
34
|
0.160
|
Female
|
130
|
28
| |
92
|
15
| |
Smoking history
| | | | | | |
Yes
|
100
|
31
|
0.395
|
97
|
25
|
0.351
|
ECOG-PS
| | | | | | |
0–1
|
261
|
67
|
0.122
|
214
|
44
|
0.500
|
2–3
|
13
|
7
| |
8
|
5
| |
Cancer typea
| | | | | | |
Adenocarcinoma
|
261
|
–
| |
210
|
–
| |
Squamous cell carcinoma
|
5
|
–
| |
2
|
–
| |
Small cell lung cancer
|
8
|
–
| |
10
|
–
| |
No-lung cancer typeb
| | | | | | |
Tuberculosis
|
–
|
28
| |
–
|
24
| |
Bacterial infections
|
–
|
13
| |
–
|
8
| |
Other diseases
|
–
|
33
| |
–
|
17
| |
- MPE, malignant pleural effusion; BPE, benign pleural effusion; EGFR, epidermal growth factor receptor; ECOG, eastern cooperative oncology group; PS, performance status
- aThe value of % was calculated among the number of cancer type
- bThe value of % was calculated among the number of no-lung cancer type